Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframe蛋白质组学和个性化PDX模型识别出在可操作时间框架内针对进展性恶性肿瘤的治疗方案EMBO MOLECULAR MEDICINEIF8.32025-04-010OA
Statistical Testing for Protein Equivalence Identifies Core Functional Modules Conserved across 360 Cancer Cell Lines and Presents a General Approach to Investigating Biological SystemsJOURNAL OF PROTEOME RESEARCHIF3.62024-05-281PRE
Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemiaNATURE COMMUNICATIONSIF15.72023-11-213OAAI
PDX models reflect the proteome landscape of pediatric acute lymphoblastic leukemia but divert in select pathwaysJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHIF12.82021-03-1517OAAI
Sensitive Determination of Proteolytic Proteoforms in Limited Microscale Proteome SamplesMOLECULAR & CELLULAR PROTEOMICSIF5.52019-11-0166OAAI